Search Results

There are 7260 results for: content related to: Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?

  1. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 4, April 2008, Pages: 312–328, R. E. Buckingham and A. Hanna

    Version of Record online : 16 JAN 2007, DOI: 10.1111/j.1463-1326.2006.00700.x

  2. Thiazolidinediones as PPAR Agonists

    Standard Article

    International Textbook of Diabetes Mellitus

    Sunder Mudaliar and Robert R. Henry

    Published Online : 15 MAR 2004, DOI: 10.1002/0470862092.d0611

  3. Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 785–796, Kristian B. Filion, Lawrence Joseph, Jean-François Boivin, Samy Suissa and James M. Brophy

    Version of Record online : 13 JUN 2011, DOI: 10.1002/pds.2165

  4. Thiazolidinediones: a new class of antidiabetic drugs

    Diabetic Medicine

    Volume 16, Issue 3, March 1999, Pages: 179–192, C. Day

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1464-5491.1999.00023.x

  5. Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update

    Fundamental & Clinical Pharmacology

    Volume 22, Issue 3, June 2008, Pages: 247–264, Pantelis A. Sarafidis

    Version of Record online : 15 APR 2008, DOI: 10.1111/j.1472-8206.2008.00568.x

  6. Cardiovascular effects of the thiazolidinediones

    Diabetes/Metabolism Research and Reviews

    Volume 22, Issue 2, March/April 2006, Pages: 88–97, Rehan Qayyum and Peter Schulman

    Version of Record online : 26 SEP 2005, DOI: 10.1002/dmrr.596

  7. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications

    Diabetes/Metabolism Research and Reviews

    Volume 25, Issue 2, February 2009, Pages: 112–126, Andrew Krentz

    Version of Record online : 13 FEB 2009, DOI: 10.1002/dmrr.937

  8. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 10, October 2015, Pages: 1026–1035, Jason C. Hsu, Ching-Lan Cheng, Dennis Ross-Degnan, Anita K. Wagner, Fang Zhang, Yea-Huei Kao Yang, Li-Ling Liu, Hsueh-Yung Tai, Ke-Hsin Chen, Po-Wen Yang and Christine Y. Lu

    Version of Record online : 6 AUG 2015, DOI: 10.1002/pds.3834

  9. Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-γ ligands on t helper type 1 chemokine regulation include nontranscriptional control mechanisms

    Inflammatory Bowel Diseases

    Volume 11, Issue 3, March 2005, Pages: 244–252, Katherine L Schaefer, Svetlana Denevich, Chen Ma, Shane R Cooley, Atsushi Nakajima, Koichiro Wada, Jennifer Schlezinger, David Sherr and Lawrence J Saubermann

    Version of Record online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000160770.94199.9b

  10. You have free access to this content
    Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus


    Volume 55, Issue 5, May 2012, Pages: 1462–1472, Chia-Hsuin Chang, Jou-Wei Lin, Li-Chiu Wu, Mei-Shu Lai, Lee-Ming Chuang and K. Arnold Chan

    Version of Record online : 19 APR 2012, DOI: 10.1002/hep.25509

  11. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 6, November 2007, Pages: 879–888, M. Yamanaka, Y. Itakura, A. Tsuchida, T. Nakagawa, H. Noguchi and M. Taiji

    Version of Record online : 14 NOV 2006, DOI: 10.1111/j.1463-1326.2006.00675.x

  12. Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones

    Diabetes, Obesity and Metabolism

    Volume 7, Issue 6, November 2005, Pages: 675–691, C. J. Bailey

    Version of Record online : 3 MAY 2005, DOI: 10.1111/j.1463-1326.2005.00497.x

  13. You have free access to this content
    PPAR-γ Agonism for Cardiovascular and Renal Protection

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: 377–384, Pantelis A. Sarafidis, Panagiotis I. Georgianos and Anastasios N. Lasaridis

    Version of Record online : 15 SEP 2010, DOI: 10.1111/j.1755-5922.2010.00222.x


    Clinical and Experimental Pharmacology and Physiology

    Volume 36, Issue 5-6, May/June 2009, Pages: 478–486, Romana S Mughal, Philip Warburton, David J O’Regan, Stephen G Ball, Neil A Turner and Karen E Porter

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1440-1681.2008.05088.x

  15. Thiazolidinedione-induced skeletal fragility – mechanisms and implications

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 4, April 2009, Pages: 275–284, Andrew Grey

    Version of Record online : 30 JUL 2008, DOI: 10.1111/j.1463-1326.2008.00931.x

  16. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents

    Diabetes/Metabolism Research and Reviews

    Volume 24, Issue 1, January 2008, Pages: 14–26, Antonio Ceriello

    Version of Record online : 7 NOV 2007, DOI: 10.1002/dmrr.790

  17. You have full text access to this Open Access content
    PPARγ activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFβ signalling

    Journal of Cellular and Molecular Medicine

    Volume 11, Issue 1, January/February 2007, Pages: 71–87, Mohammed H. Jarrar and Ancha Baranova

    Version of Record online : 15 MAR 2007, DOI: 10.1111/j.1582-4934.2007.00003.x

  18. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  19. Differentiating members of the thiazolidinedione class: a focus on efficacy

    Diabetes/Metabolism Research and Reviews

    Volume 18, Issue S2, March/April 2002, Pages: S16–S22, Barry J. Goldstein

    Version of Record online : 21 MAR 2002, DOI: 10.1002/dmrr.251

  20. You have free access to this content
    Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis


    Volume 62, Issue 5, November 2015, Pages: 1417–1432, Siddharth Singh, Rohan Khera, Alina M. Allen, M. Hassan Murad and Rohit Loomba

    Version of Record online : 1 OCT 2015, DOI: 10.1002/hep.27999